Towards quality control in cancer chemotherapy

British Journal of Cancer

Volumn 73, Issue 1, 1996, Pages 117-118

  Woodman, C ^a   Nicolson, M ^a   Hare, L ^a   So, J ^a   Hey, R ^b   McIllmurray, M ^c   Crowther, D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

^c ROYAL LANCASTER INFIRMARY   (United Kingdom)

Author keywords

Audit; Delivery of cancer chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; DRUG SYNTHESIS; HOSPITAL PHARMACY; HUMAN; MEDICAL EDUCATION; PRIORITY JOURNAL; QUALITY CONTROL; UNITED KINGDOM;

EID: 0030029264     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.21     Document Type: Article

References (18)

1. CARDEN P. (1991). Pharmacist exposure to cytotoxic drugs (letter). Aust. J. Hosp. Pharm., 21, 192.
2. GABRIELE P, AIROLDI M, SUCCO G, BRANDO V AND REDDA MGR. (1993). Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents (letter). Eur. J. Cancer-Oral Oncol., 29B, 153.
3. HEALTH AND SAFETY EXECUTIVE. (1983). Precautions for the Safe Handling of Cytotoxic Drugs. Guidance Note MS21. Medical Series 21. HSE: London.
4. HEMMINKI K, KYYRONEN P AND LINDBOHM M. (1985). Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytotoxic drugs and other potential hazards in hospitals, based on registered information of outcome. J. Epidemiol. Community Health, 39, 141-147.
5. HUDSON G.(1990). The toxic ecology of work. Are the carers taking care? Aust. Nursing J., 19, 17.
6. JOINT COUNCIL FOR CLINICAL ONCOLOGY. (1994). Quality Control in Cancer Chemotherapy: Managerial and Procedural Aspects. JCCO: London.
7. LEVIN LI, HOLLY EA AND SEWARD JP. (1993). Bladder cancer in a 39-year-old female pharmacist (letter). J. Natl Cancer Inst., 85, 1089-1090.
8. MCDONALD AD, MCDONALD JC, ARMSTRONG B, CHERRY NM, COTE R, LAVOIE J, NOLIN AD AND ROBERT D. (1988). Congenital defects and work in pregnancy. Br. J. Ind. Med., 45, 581-588.
9. OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION. (1986). Work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. OSHA Instructions Publication 8-1.1. Office of Occupational Medicine, US Dept of Labor: Washington DC.
10. PHARMACEUTICAL SOCIETY WORKING PARTY. (1983). Guidelines for the handling of cytotoxic drugs. Pharm. J., 230, 230-233.
11. RODRIGUEZ P AND YAP CY. (1991). Abnormal blood results found in pharmacists preparing cytotoxics (letter). Aust. J. Hosp. Pharm., 21, 39.
12. SELEVAN SG, LINDBOHM M, HORNUNG RW AND HEMMINKI K. (1985). A study of occupational exposure to antineoplastics drugs and fetal loss in nurses. N. Engl. J. Med., 313, 1173-1178.
13. SKOV T. (1993). Handling antineoplastic drugs in the European Community countries. Eur. J. Cancer Prev., 2, 43-46.
14. SKOV T, LYNGE E, MAARUP B, OLSEN J, RØRTH M AND WINTHEREIK H. (1990). Risk for physicians handling antineoplastic drugs (letter). Lancet, 336, 1446.
15. SKOV T, MAARUP E, OLSEN J, RØRTH M, WINTHEREIK H AND LYNGE E. (1992). Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J. Ind. Med., 49, 855-861.
16. STUCKER I, CAILLARD JF, COLLIN R, GOUT M, POYEN D AND HEMON D. (1990). Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand. J. Work Environ. Health, 16, 102-107.
17. 'YOU'LL DIE,' DOCTOR TELLS PATIENT AFTER MISTAKE. Sunday Times, 21 November 1993, p 3.
18. ZARAGOZA MR, RITCHEY ML AND WALTER A. (1995). Neurologic consequences of accidental intrathecal vineristine: a case report. Med. Paediatr. Oncol., 24, 61-62.